Injected Anandamide Produced Both Spontaneous and Antagonist-Precipitated Withdrawal in Rats

Repeated injections of anandamide produced tolerance and withdrawal-related behavior in rats, including after dosing stopped and after a CB1 antagonist challenge. Because the endogenous signaling molecule was administered as a drug, the finding cannot be equated with ordinary physiological endocannabinoid release.

The exposure was experimentally imposed

The 2000 study administered anandamide daily for two weeks. Calling anandamide endogenous identifies its biological role, but does not make an injected repeated-dose regimen equivalent to normal local synthesis and breakdown. The experiment tested what exogenous administration could produce in rats, rather than whether the body's unmanipulated signaling system causes a human withdrawal disorder.

Two withdrawal procedures yielded observations

Investigators assessed interruption of dosing with vehicle substitution and, separately, administration of SR141716A to precipitate withdrawal. The abstract reports an abstinence syndrome under both approaches. Those procedures address different conditions: cessation of exposure versus receptor antagonism after adaptation. Their agreement supports a dependence-related interpretation in this model without making the procedures interchangeable.

Tolerance was not uniform across responses

Full or partial tolerance developed to several cannabinoid-like effects, including reduced temperature, catalepsy and reduced movement. Reduced defecation did not show tolerance. The result therefore does not support a blanket assertion that every anandamide effect faded. The observed withdrawal signs were animal behaviors, not direct measurements of human craving, distress or driving ability.

Interpreting the evidence

This experiment distinguishes an endogenous ligand's identity from the consequences of administering it repeatedly. It supports tolerance and physical-dependence findings for the studied rat regimen, while leaving normal human signaling, clinical risk and the effects of plant cannabis as separate questions.

Related reading: receptor adaptation and human evidence.

Research reference

Costa B; Giagnoni G; Colleoni M (2000). Precipitated and spontaneous withdrawal in rats tolerant to anandamide. Psychopharmacology. doi:10.1007/s002139900360. Evidence basis: study abstract.